← FDA Drug Approvals (Drugs@FDA)

DEFERASIROX

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2024-05-03

Drug application

FDA Application #

ANDA213146

Application type

Abbreviated New Drug Application (Generic)

Brand name

DEFERASIROX

Generic name

Deferasirox

Active ingredients

DEFERASIROX

Dosage form

GRANULE

Route

ORAL

Marketing status

Discontinued

Sponsor

PHARMOBEDIENT

First approval

2024-05-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown